Lindbrook Capital, LLC - VERVE THERAPEUTICS INC ownership

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 69 filers reported holding VERVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of VERVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,193
+19.3%
90
+136.8%
0.00%
Q3 2022$1,000
-94.4%
38
-87.3%
0.00%
-100.0%
Q2 2021$18,0003000.00%
Other shareholders
VERVE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alphabet Inc. 10,974,011$515,778,00012.24%
Casdin Capital, LLC 3,038,167$142,794,0003.55%
Redmile Group, LLC 1,869,030$87,844,0001.53%
Logos Global Management LP 443,265$20,833,0001.50%
Novo Holdings A/S 600,000$28,200,0001.46%
Cormorant Asset Management, LP 709,224$32,667,0001.33%
Rock Springs Capital Management LP 962,826$45,253,0000.95%
HighVista Strategies LLC 18,782$883,0000.58%
RA Capital Management 880,284$41,373,0000.57%
Nicholas Investment Partners, LP 132,300$6,218,0000.45%
View complete list of VERVE THERAPEUTICS INC shareholders